Drug Profile
Research programme: pain therapeutics - Domain Therapeutics/ Conectus
Alternative Names: Neuropeptide FF - Domain Therapeutics/Conectus; THIAPO 2Latest Information Update: 28 Oct 2020
Price :
$50
*
At a glance
- Originator Domain Therapeutics
- Class Analgesics
- Mechanism of Action Neuropeptide modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Pain
Most Recent Events
- 28 Oct 2020 No recent reports of development identified for research development in Pain in France
- 19 Sep 2016 Early research in Pain in France (unspecified route) before September 2016